234 related articles for article (PubMed ID: 33772213)
1. IDH-mutant gliomas with additional class-defining molecular events.
Ahrendsen JT; Torre M; Meredith DM; Hornick JL; Reardon DA; Wen PY; Yeo KK; Malinowski S; Ligon KL; Ramkissoon S; Alexandrescu S
Mod Pathol; 2021 Jul; 34(7):1236-1244. PubMed ID: 33772213
[TBL] [Abstract][Full Text] [Related]
2. Additional genetic alterations in BRAF-mutant gliomas correlate with histologic diagnoses.
Dono A; Vu J; Anapolsky M; Hines G; Takayasu T; Yan Y; Tandon N; Zhu JJ; Bhattacharjee MB; Esquenazi Y; Ballester LY
J Neurooncol; 2020 Sep; 149(3):463-472. PubMed ID: 33009979
[TBL] [Abstract][Full Text] [Related]
3. Sensitive and rapid detection of TERT promoter and IDH mutations in diffuse gliomas.
Diplas BH; Liu H; Yang R; Hansen LJ; Zachem AL; Zhao F; Bigner DD; McLendon RE; Jiao Y; He Y; Waitkus MS; Yan H
Neuro Oncol; 2019 Mar; 21(4):440-450. PubMed ID: 30346624
[TBL] [Abstract][Full Text] [Related]
4. Targeting IDH-Mutant Glioma.
Miller JJ
Neurotherapeutics; 2022 Oct; 19(6):1724-1732. PubMed ID: 35476295
[TBL] [Abstract][Full Text] [Related]
5. Detection, Characterization, and Inhibition of FGFR-TACC Fusions in IDH Wild-type Glioma.
Di Stefano AL; Fucci A; Frattini V; Labussiere M; Mokhtari K; Zoppoli P; Marie Y; Bruno A; Boisselier B; Giry M; Savatovsky J; Touat M; Belaid H; Kamoun A; Idbaih A; Houillier C; Luo FR; Soria JC; Tabernero J; Eoli M; Paterra R; Yip S; Petrecca K; Chan JA; Finocchiaro G; Lasorella A; Sanson M; Iavarone A
Clin Cancer Res; 2015 Jul; 21(14):3307-17. PubMed ID: 25609060
[TBL] [Abstract][Full Text] [Related]
6. Infratentorial IDH-mutant astrocytoma is a distinct subtype.
Banan R; Stichel D; Bleck A; Hong B; Lehmann U; Suwala A; Reinhardt A; Schrimpf D; Buslei R; Stadelmann C; Ehlert K; Prinz M; Acker T; Schittenhelm J; Kaul D; Schweizer L; Capper D; Harter PN; Etminan N; Jones DTW; Pfister SM; Herold-Mende C; Wick W; Sahm F; von Deimling A; Hartmann C; Reuss DE
Acta Neuropathol; 2020 Oct; 140(4):569-581. PubMed ID: 32776277
[TBL] [Abstract][Full Text] [Related]
7. H3K27-altered diffuse midline gliomas with MAPK pathway alterations: Prognostic and therapeutic implications.
Gestrich C; Grieco K; Lidov HG; Baird LC; Fehnel KP; Yeo KK; Meredith DM; Alexandrescu S
J Neuropathol Exp Neurol; 2023 Dec; 83(1):30-35. PubMed ID: 38037182
[TBL] [Abstract][Full Text] [Related]
8. Astrocytoma (CNS WHO grade 4), IDH-mutant with co-occurrence of BRAF p.V600E mutation, and homozygous loss of CDKN2A.
Leske H; Blakstad H; Lund-Iversen M; Skovholt EK; Niehusmann P; Ramm-Pettersen JT; Skogen K; Kongelf G; Sprauten M; Magelssen H; Brandal P
Neuropathology; 2023 Oct; 43(5):385-390. PubMed ID: 36754566
[TBL] [Abstract][Full Text] [Related]
9. Adult brainstem gliomas: Correlation of clinical and molecular features.
Theeler BJ; Ellezam B; Melguizo-Gavilanes I; de Groot JF; Mahajan A; Aldape KD; Bruner JM; Puduvalli VK
J Neurol Sci; 2015; 353(1-2):92-7. PubMed ID: 25934342
[TBL] [Abstract][Full Text] [Related]
10. Gray Areas in the Gray Matter:
van den Bent MJ; Mellinghoff IK; Bindra RS
Am Soc Clin Oncol Educ Book; 2020 Mar; 40():1-8. PubMed ID: 32186930
[TBL] [Abstract][Full Text] [Related]
11. Treatment and outcomes of IDH1-mutant gliomas in elderly patients.
Giantini-Larsen AM; Abou-Mrad Z; Yu KK; Reiner AS; Bale TA; Tabar V; Bander ED
J Neurosurg; 2024 Feb; 140(2):367-376. PubMed ID: 37877960
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of the REST transcription factor regulatory networks in IDH mutant and IDH wild-type glioma cell lines and tumors.
Perycz M; Dabrowski MJ; Jardanowska-Kotuniak M; Roura AJ; Gielniewski B; Stepniak K; Dramiński M; Ciechomska IA; Kaminska B; Wojtas B
Acta Neuropathol Commun; 2024 May; 12(1):72. PubMed ID: 38711090
[TBL] [Abstract][Full Text] [Related]
13. Region-specific DNA hydroxymethylation along the malignant progression of IDH-mutant gliomas.
Hana T; Mukasa A; Nomura M; Nagae G; Yamamoto S; Tatsuno K; Ueda H; Fukuda S; Umeda T; Tanaka S; Nejo T; Kitagawa Y; Yamazawa E; Takahashi S; Koike T; Kushihara Y; Takami H; Takayanagi S; Aburatani H; Saito N
Cancer Sci; 2024 May; 115(5):1706-1717. PubMed ID: 38433527
[TBL] [Abstract][Full Text] [Related]
14. Tumor heterogeneity and tumor-microglia interactions in primary and recurrent IDH1-mutant gliomas.
Blanco-Carmona E; Narayanan A; Hernandez I; Nieto JC; Elosua-Bayes M; Sun X; Schmidt C; Pamir N; Özduman K; Herold-Mende C; Pagani F; Cominelli M; Taranda J; Wick W; von Deimling A; Poliani PL; Rehli M; Schlesner M; Heyn H; Turcan Ş
Cell Rep Med; 2023 Nov; 4(11):101249. PubMed ID: 37883975
[TBL] [Abstract][Full Text] [Related]
15. Metabologenomic characterization uncovers a clinically aggressive IDH mutant glioma subtype.
Nassiri F; Ajisebutu A; Patil V; Mamatjan Y; Liu J; Wang JZ; Voisin MR; Nejad R; Mansouri S; Karimi S; Chakravarthy A; Chen E; De Carvalho DD; Aldape K; Zadeh G
Acta Neuropathol; 2024 Apr; 147(1):68. PubMed ID: 38583102
[TBL] [Abstract][Full Text] [Related]
16. Molecular Profiling and Targeted Therapies in Gliomas.
Felistia Y; Wen PY
Curr Neurol Neurosci Rep; 2023 Oct; 23(10):627-636. PubMed ID: 37812369
[TBL] [Abstract][Full Text] [Related]
17. BRAF V600E mutant oligodendroglioma-like tumors with chromosomal instability in adolescents and young adults.
Fukuoka K; Mamatjan Y; Ryall S; Komosa M; Bennett J; Zapotocky M; Keith J; Myrehaug S; Hazrati LN; Aldape K; Laperriere N; Bouffet E; Tabori U; Hawkins C
Brain Pathol; 2020 May; 30(3):515-523. PubMed ID: 31630459
[TBL] [Abstract][Full Text] [Related]
18. Exceptionally rare IDH1-mutant adult medulloblastoma with concurrent GNAS mutation revealed by in vivo magnetic resonance spectroscopy and deep sequencing.
Liserre R; Branzoli F; Pagani F; Gryzik M; Cominelli M; Miele E; Marjańska M; Doglietto F; Poliani PL
Acta Neuropathol Commun; 2023 Mar; 11(1):47. PubMed ID: 36941703
[TBL] [Abstract][Full Text] [Related]
19. Methylation and transcription patterns are distinct in IDH mutant gliomas compared to other IDH mutant cancers.
Unruh D; Zewde M; Buss A; Drumm MR; Tran AN; Scholtens DM; Horbinski C
Sci Rep; 2019 Jun; 9(1):8946. PubMed ID: 31222125
[TBL] [Abstract][Full Text] [Related]
20. GlioPredictor: a deep learning model for identification of high-risk adult IDH-mutant glioma towards adjuvant treatment planning.
Zheng S; Rammohan N; Sita T; Teo PT; Wu Y; Lesniak M; Sachdev S; Thomas TO
Sci Rep; 2024 Jan; 14(1):2126. PubMed ID: 38267516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]